MADISON, Wis.--(BUSINESS WIRE)--HealthMyne Inc., an innovator in the emerging field of quantitative imaging decision support software, today launched a new website and unveiled refreshed branding as an extension of the company’s strategic vision.
Due to volume demands and lack of state-of-the-art tools, radiologists struggle to deliver consistent, standardized data to their referrers, resulting in unnecessary gaps in communication and collaboration. HealthMyne’s Quantitative Imaging Decision Support (QIDS)™ software platform addresses these challenges by providing clinical decision support within the clinical read and back out to the multidisciplinary team to enable precise patient management and drive clinical productivity.
“The healthcare landscape is changing rapidly and HealthMyne is at the center of this transformation,” said HealthMyne CEO Arvind Subramanian. “Historically, radiologists were focused on volume, but now with changes to reimbursement and quality reporting, they are investing in technology, processes and innovation that deliver value.” HealthMyne’s refreshed logo and branding visually represent the company’s unique ability to help clinicians find the intersection where volume and value coexist.
The new mobile-optimized website, www.healthmyne.com, incorporates the company’s refined brand identity and delivers a seamless user experience and rich, solution-focused content that addresses how HealthMyne fosters collaboration by delivering value across multiple clinical specialties starting with oncology.
According to Subramanian, thoroughly defining QIDS (pronounced KWIDS), was one of the highest priorities with the new website. QIDS is the company’s FDA-cleared software platform that delivers image quantification, analytics and clinical information into the primary workflow.
The new website will expand to include a host of educational materials including clinician-authored white papers and opportunities to participate in webinars for continued learning.
Editor’s note: High resolution logo files and screenshots of HealthMyne’s new website are available upon request.
HealthMyne, Inc. is focused on delivering Quantitative Imaging Decision Support (QIDS)™ for Radiology and Oncology with expansion to other clinical specialties and non-US markets over time. The company’s FDA-cleared software platform delivers image quantification, analytics and clinical information (EMR, RT, other data) into the primary workflow to drive clinical productivity; provides curated medical content, analysis and reporting to optimize clinical collaboration and enable precise patient management; and supports data mining for clinical, translational and commercial research.